000			01715 a2200505 4500
005			20250515121153.0
264		0	_c20080624
008			200806s 0 0 eng d
022			_a1873-4456
024	7		_a10.1016/j.cancergencyto.2008.02.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aPaiva, Márcia
245	0	0	_aFcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients. _h[electronic resource]
260			_bCancer genetics and cytogenetics _cMay 2008
300			_a35-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntigens, CD _xgenetics
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPharmacogenetics
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPrognosis
650	0	4	_aReceptors, IgG _xgenetics
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aMarques, Herlander
700	1		_aMartins, Angelo
700	1		_aFerreira, Paula
700	1		_aCatarino, Raquel
700	1		_aMedeiros, Rui
773	0		_tCancer genetics and cytogenetics _gvol. 183 _gno. 1 _gp. 35-40
856	4	0	_uhttps://doi.org/10.1016/j.cancergencyto.2008.02.001 _zAvailable from publisher's website
999			_c17969261 _d17969261